You’re using a public version of DrugPatentWatch with 1 free search available | Register to unlock more free searches. CREATE FREE ACCOUNT

Serving leading biopharmaceutical companies globally:

Last Updated: November 28, 2023

Drug Price Trends for GIVLAARI

✉ Email this page to a colleague

« Back to Dashboard

Best Wholesale Price for GIVLAARI

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available to any customer under comparable terms and conditions

Subscribe to access the full database, or Try a Trial

Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies
Drug Name	Vendor	NDC	Count	Price ($)	Price/Unit ($)	Unit	Dates	Price Type
GIVLAARI 189MG/ML	Alnylam Pharmaceuticals, Inc.	71336-1001-01	1ML	29047.45	29047.45000	ML	2022-01-01 - 2024-01-31	Big4
GIVLAARI 189MG/ML	Alnylam Pharmaceuticals, Inc.	71336-1001-01	1ML	38412.06	38412.06000	ML	2022-01-01 - 2024-01-31	FSS
GIVLAARI 189MG/ML	Alnylam Pharmaceuticals, Inc.	71336-1001-01	1ML	29440.36	29440.36000	ML	2023-01-01 - 2024-01-31	Big4
GIVLAARI 189MG/ML	Alnylam Pharmaceuticals, Inc.	71336-1001-01	1ML	38412.06	38412.06000	ML	2023-01-01 - 2024-01-31	FSS
>Drug Name	>Vendor	>NDC	>Count	>Price ($)	>Price/Unit ($)	>Unit	>Dates	>Price Type

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson

Johnson and Johnson

AstraZeneca

Moodys

Mallinckrodt

Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.